Quantitative and qualitative evaluation of antimicrobial usage: the first step for antimicrobial stewardship

키워드

참고문헌 (71)

1. Spellberg B, "The epidemic of antibiotic-resistant infections : a call to action for the medical community from the Infectious Diseases Society of America", Clin Infect Dis, 46, pp.155~164 (2008)
2. Cassini A, "Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015 : a population-level modelling analysis", Lancet Infect Dis, 19, pp.56~66 (2019)
3. Touat M, "Costs and outcomes of 1-year post-discharge care trajectories of patients admitted with infection due to antibiotic-resistant bacteria", J Infect, 82, pp.339~345 (2021)
4. "Comprehensive review of the WHO Global Action Plan on Antimicrobial Resistance : Evaluation brief – September 2021" (2021)[URL]
5. Hwang S, "Core elements for successful implementation of antimicrobial stewardship programs", Infect Chemother, 53, pp.421~435 (2021)
6. Yoon YK, "Guidelines on implementing antimicrobial stewardship programs in Korea", Infect Chemother, 53, pp.617~659 (2021)
7. Barlam TF, "Implementing an antibiotic stewardship program : guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America", Clin Infect Dis, 62, pp.e51~e77 (2016)
8. Hwang H, "Impact of an infectious diseases specialist-led antimicrobial stewardship programmes on antibiotic use and antimicrobial resistance in a large Korean hospital", Sci Rep, 8, pp.14757~ (2018)
9. Shin DH, "Stepwise expansion of antimicrobial stewardship programs and its impact on antibiotic use and resistance rates at a tertiary care hospital in Korea", Microbiol Spectr, 10, pp.e0033522~ (2022)
10. Heo E, "Current status of outpatient parenteral antimicrobial therapy in Korea : experience of a single university-affiliated acute-care hospital", Infect Chemother, 55, pp.185~193 (2023)
11. Yarrington ME, "Basic, advance, and novel metrics to guide antibiotic use assessments", Curr Treat Opt Infect Dis, 11, pp.145~160 (2019)
12. "WHO report on surveillance of antibiotic consumption: 2016-2018 early implementation" (2019)[URL]
13. Pollack LA, "Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention", Clin Infect Dis, 59(Suppl 3), pp.S97~S100 (2014)
14. Cheong HS, "Core elements for implementing antimicrobial stewardship programs in Korean general hospitals", Infect Chemother, 54, pp.637~673 (2022)
15. Cheong HS, "Developing core elements and checklist items for implementing antimicrobial stewardship programs in Korean general hospitals : a modified Delphi survey", Infect Chemother, 55, pp.59~68 (2023)
16. "National action plan on antimicrobial resistance (2021-2025)"[URL]
17. Park SY, "Current status and prospect of qualitative assessment of antibiotics prescriptions", Infect Chemother, 54, pp.599~609 (2022)
18. Kim B, "Ten-year trends in antibiotic usage at a tertiary care hospital in Korea, 2004 to 2013", Korean J Intern Med, 35, pp.703~713 (2020)
19. "2021 AWaRe classification" (2021)[URL]
20. O’Leary EN, "National Healthcare Safety Network Standardized Antimicrobial Administration Ratios(SAARs) : a progress report and risk modeling update using 2017 data", Clin Infect Dis, 71, pp.e702~e709 (2020)
21. Kim B, "Development of antibiotic classification for measuring antibiotic usage in Korean Hospitals using a modified Delphi method", J Korean Med Sci, 35, pp.e241~ (2020)
22. Morris AM, "Antimicrobial stewardship programs : appropriate measures and metrics to study their impact", Curr Treat Options Infect Dis, 6, pp.101~112 (2014)
23. "Annual report on antimicrobial use in Korean hospitals: Results of 58 participating hospitals in 2022" (2023)[URL]
24. Reddy SC, "Antibiotic use in US hospitals : quantification, quality measures and stewardship", Expert Rev Anti Infect Ther, 13, pp.843~854 (2015)
25. Kim B, "A few antibiotics can represent the total hospital antibiotic consumption", BMC Infect Dis, 18, pp.247~ (2018)
26. Kim B, "Development of the Korean standardized antimicrobial administration ratio as a tool for benchmarking antimicrobial use in each hospital", J Korean Med Sci, 37, pp.e191~ (2022)
27. "National Antimicrobial Utilisation Surveillance Program: 2019Key Findings" (2021)[URL]
28. "MedicineInsight" (2023)[URL]
29. "Antimicrobial use and resistance (AUR) module" (2024)[URL]
30. "AMR local indicators - produced by the UKHSA" (2023)[URL]
31. "English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report" (2014)[URL]
32. "Canadian Antimicrobial Resistance Surveillance System (CARSS) report 2022" (2022)[URL]
33. Kagami K, "Correlation between antibiotic use and antibiotic resistance : a multicenter study using the Japan Surveillance for Infection Prevention and Healthcare Epidemiology(J-SIPHE)system in Hokkaido, Japan", Am J Infect Control, 51, pp.163~171 (2023)
34. "Surveillance for Infection Prevention and Healthcare Epidemiology (J-SIPHE) Annual Report 2021" (2022)[URL]
35. Ryu S, "The new Korean action plan for containment of antimicrobial resistance", J Glob Antimicrob Resist, 8, pp.70~73 (2017)
36. Kim B, "Significance of the regular publication of statistics on national health indicators in academic journals and the prospects of Korea National Antimicrobial Use Analysis System(KONAS)", Infect Chemother, 55, pp.306~307 (2023)
37. Kim Y, "Trends in national pharmaceutical expenditure in Korea during 2011-2020", Infect Chemother, 55, pp.237~246 (2023)
38. Kim HS, "Development of a roadmap for the antimicrobial usage monitoring system for medical institutions in Korea : a Delphi study", Infect Chemother, 54, pp.483~492 (2022)
39. Gyssens IC, "Quality measures of antimicrobial drug use", Int J Antimicrob Agents, 17, pp.9~19 (2001)
40. van den Bosch CM, "Quality indicators to measure appropriate antibiotic use in hospitalized adults", Clin Infect Dis, 60, pp.281~291 (2015)
41. Aviatin M, "Evaluation of the use of antimicrobial therapy for treating diabetic foot infections in an Indonesia referral hospital : a retrospective cohort study", Infect Chemother, 55, pp.80~89 (2023)
42. Le Maréchal M, "Quality indicators assessing antibiotic use in the outpatient setting : a systematic review followed by an international multidisciplinary consensus procedure", J Antimicrob Chemother, 73(suppl_6), pp.vi40~vi49 (2018)
43. Monnier AA, "Quality indicators for responsible antibiotic use in the inpatient setting : a systematic review followed by an international multidisciplinary consensus procedure", J Antimicrob Chemother, 73(suppl_6), pp.vi30~vi39 (2018)
44. Schoffelen T, "Quality indicators for appropriate antimicrobial therapy in the emergency department : a pragmatic Delphi procedure", Clin Microbiol Infect, 27, pp.210~214 (2021)
45. Kim B, "Development of key quality indicators for appropriate antibiotic use in the Republic of Korea : results of a modified Delphi survey", Antimicrob Resist Infect Control, 10, pp.48~ (2021)
46. Magill SS, "Assessment of the appropriateness of antimicrobial use in US hospitals", JAMA Netw Open, 4, pp.e212007~ (2021)
47. "National Antimicrobial Prescribing Survey" (2018)[URL]
48. Magill SS, "Prevalence of healthcare-associated infections in acute care hospitals in Jacksonville, Florida", Infect Control Hosp Epidemiol, 33, pp.283~291 (2012)
49. Fridkin S, "Vital signs : improving antibiotic use among hospitalized patients", MMWR Morb Mortal Wkly Rep, 63, pp.194~200 (2014)
50. Magill SS, "Prevalence of antimicrobial use in US acute care hospitals, May-September 2011", JAMA, 312, pp.1438~1446 (2014)
51. "Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2011-2012" (2013)[URL]
52. "Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2016-2017" (2023)[URL]
53. "Point prevalence survey of healthcare-associated infections and antimicrobial use in European long-term care facilities. May-September 2010" (2014)[URL]
54. "Point prevalence survey of healthcare-associated infections and antimicrobial use in European long-term care facilities. April-May 2013" (2014)[URL]
55. "Point prevalence survey of healthcare-associated infections and antimicrobial use in European long-term care facilities 2016-2017" (2023)[URL]
56. "Antimicrobial prescribing practice in Australian hospitals. Results of the 2020 Hospital National Antimicrobial Prescribing Survey" (2023)[URL]
57. "Surgical prophylaxis prescribing in Australian hospitals. Results of the 2020 Hospital National Antimicrobial Prescribing Survey" (2023)[URL]
58. "Antimicrobial prescribing practice in Australian residential aged care facilities. Results of the 2020Hospital National Antimicrobial Prescribing Survey" (2023)[URL]
59. Kim BN, "Antibiotic control policies in South Korea, 2000-2013", Infect Chemother, 48, pp.151~159 (2016)
60. Kim ES, "Impact of a national hospital evaluation program using clinical performance indicators on the use of surgical antibiotic prophylaxis in Korea", Int J Infect Dis, 16, pp.e187~e192 (2012)
61. Park SY, "Appropriateness of antibiotic prescriptions during hospitalization and ambulatory care : a multicentre prevalence survey in Korea", J Glob Antimicrob Resist, 29, pp.253~258 (2022)
62. Jung J, "Appropriateness of antibiotic use for patients with asymptomatic bacteriuria or urinary tract infection with positive urine culture : a retrospective observational multi-centre study in Korea", J Hosp Infect, 140, pp.79~86 (2023)
63. Kim YC, "Prescriptions patterns and appropriateness of usage of antibiotics in non-teaching community hospitals in South Korea : a multicentre retrospective study", Antimicrob Resist Infect Control, 11, pp.40~ (2022)
64. Kim SW, "Drug use evaluation of intravenous ciprofloxacin in university hospitals in Korea", Infect Chemother, 36, pp.350~356 (2004)
65. Nam EY, "Appropriateness of surgical antibiotic prophylaxis in a tertiary hospital", Korean J Nosocomial Infect Control, 19, pp.64~70 (2014)
66. Lee MJ, "Why is asymptomatic bacteriuria overtreated? : a tertiary care institutional survey of resident physicians", BMC Infect Dis, 15, pp.289~ (2015)
67. Kim HI, "A 2011-2012survey of doctors’ perceptions of Korean guidelines and empirical treatment of community-acquired pneumonia", Infect Chemother, 45, pp.394~405 (2013)
68. Kim SW, "Antimicrobial stewardship with intravenous to oral conversion and future directions of antimicrobial stewardship", Infect Chemother, 49, pp.87~89 (2017)
69. Park SM, "Impact of intervention by an antimicrobial stewardship team on conversion from intravenous to oral fluoroquinolones", Infect Chemother, 49, pp.31~37 (2017)
70. Kang J, "Evaluation of the appropriateness of empirical antibiotic prescription after implementation of antibiotic treatment guidelines for pneumonia in a hospital", J Korean Soc Health Syst Pharm, 35, pp.391~399 (2018)
71. Song YJ, "Impact of an antimicrobial stewardship program on unnecessary double anaerobic coverage prescription", Infect Chemother, 47, pp.111~116 (2015)

관련 논문AI추천